- Home
- TACT vs ANTX Comparison
TACT vs ANTX Comparison
Compare TACT & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- ANTX
- Stock Information
- Founded
- TACT 1996
- ANTX 2017
- Country
- TACT United States
- ANTX United States
- Employees
- TACT N/A
- ANTX N/A
- Industry
- TACT Computer peripheral equipment
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- ANTX Health Care
- Exchange
- TACT Nasdaq
- ANTX Nasdaq
- Market Cap
- TACT 35.7M
- ANTX 33.2M
- IPO Year
- TACT 1996
- ANTX 2022
- Fundamental
- Price
- TACT $3.66
- ANTX $1.09
- Analyst Decision
- TACT Strong Buy
- ANTX Buy
- Analyst Count
- TACT 1
- ANTX 2
- Target Price
- TACT $5.00
- ANTX $2.00
- AVG Volume (30 Days)
- TACT 13.9K
- ANTX 286.6K
- Earning Date
- TACT 08-07-2025
- ANTX 08-12-2025
- Dividend Yield
- TACT N/A
- ANTX N/A
- EPS Growth
- TACT N/A
- ANTX N/A
- EPS
- TACT N/A
- ANTX N/A
- Revenue
- TACT $45,750,000.00
- ANTX N/A
- Revenue This Year
- TACT $14.81
- ANTX N/A
- Revenue Next Year
- TACT N/A
- ANTX N/A
- P/E Ratio
- TACT N/A
- ANTX N/A
- Revenue Growth
- TACT N/A
- ANTX N/A
- 52 Week Low
- TACT $3.12
- ANTX $0.87
- 52 Week High
- TACT $5.11
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- TACT 52.14
- ANTX 48.32
- Support Level
- TACT $3.62
- ANTX $1.07
- Resistance Level
- TACT $3.84
- ANTX $1.10
- Average True Range (ATR)
- TACT 0.22
- ANTX 0.05
- MACD
- TACT 0.01
- ANTX 0.00
- Stochastic Oscillator
- TACT 66.04
- ANTX 35.71
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.